Remote ALS Strategy & Market Access Liaison

Otsuka America Pharmaceutical Inc.; Phoenix (AZ); Remote; USD 158,000 - 252,000; Full time

Job summary

Otsuka America Pharmaceutical Inc. is seeking a Remote Strategic Account Liaison to launch and grow FUS-ALS for ALS Centers of Excellence and healthcare providers.

This field-based role focuses on communicating complex clinical data, screening/treatment pathways, and access to patient support programs to advance patient care. The SAL will collaborate with cross-functional teams and external customers to drive performance, while evolving with future rare neurology programs.

Qualifications

• Understanding complex disease states and ability to articulate clinical data
• Educate on screening, diagnostic pathways and urgent patient prioritization
• Builds relationships with HCPs and Key Opinion Leaders (KOLs)
• Facilitates access and patient support program information for therapy
• Participates in conferences and scientific meetings to educate on rare neurology

Responsibilities

• Effectively communicate complex clinical data to ALS Centers of Excellence, HCPs, and stakeholders
• Develop strategic account plans and regional strategies using data sources and market insights
• Navigate site of care, patient onboarding, and therapy initiation barriers
• Identify and manage ALS referral networks and centers of excellence for program pull-through
• Collaborate with Thought Leaders, MS Liaisons, Case Managers, and Leadership to meet objectives
• Engage in training programs to understand brand strategy and policy compliance

Skills

Clinical acumen

HCP engagement

KOL engagement

Cross-functional teamwork

Account management

Market access

Treatment logistics

Education

Bachelor’s Degree

Job description

Otsuka America Pharmaceutical Inc. is seeking a Remote Strategic Account Liaison to launch and grow FUS-ALS for ALS Centers of Excellence and healthcare providers.

This field-based role focuses on communicating complex clinical data, screening/treatment pathways, and access to patient support programs to advance patient care. The SAL will collaborate with cross-functional teams and external customers to drive performance, while evolving with future rare neurology programs.